Evidence map›Paper›PMID 28233357›Full record

ArticleGenes, chromosomes & cancer2017

Promotion of invasion by mutant RAS is dependent on activation of the WASF3 metastasis promoter gene.

Yong Teng, Lambert Ngoka, John K Cowell

Abstract read
In one paragraph

Article in Genes, chromosomes & cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Targeting WASF3 Signaling in Metastatic Cancer.International journal of molecular sciences · 2021
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Yong TengThe Georgia Cancer Center, Augusta University, Augusta, Georgia, USA.
Lambert NgokaThe Georgia Cancer Center, Augusta University, Augusta, Georgia, USA.
John K CowellThe Georgia Cancer Center, Augusta University, Augusta, Georgia, USA.ORCID 0000-0002-2079-5950
Augusta University Health · US

Funding

Functional analysis of the WAVE3 geneR01CA120510 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI COWELL, JOHN K · 2007 to 2011
$1.7M
NCI NIH HHS R01 CA120510
6 · The paper itself

Abstract

Metastasis represents an end stage in the evolution of cancer progression and has been related to specific genetic pathways. Overexpression of mutant RAS in particular appears to promote invasion and metastasis, although exactly how this occurs has not been well characterized. It was previously showed that activation of the WASF3 protein regulates actin cytoskeleton dynamics that promote invasion. In this report, how WASF3 overexpression interacts with mutant RAS to increase invasion and metastasis was investigated. The ability of RAS to promote invasion and metastasis was shown to be dependent on WASF3 activation in a PI3K and AKT dependent manner. Proteomics analysis demonstrates the presence of AKT in the WASF3 immunocomplex which is enhanced by overexpression of mutant RAS. During these processes activation of ERK1/2 is not affected by loss of WASF3 expression. Analysis of the relative involvement of p85 and p110 in the WASF3 complex demonstrates that mutant RAS promotes dissociation of p85 promoting activation of p110. These studies provide a deeper understanding of the critical role for WASF3 in facilitating increased invasion potential in cancer cells expressing mutant RAS and supports the idea that targeting WASF3 in metastatic cells overexpressing RAS may be used to suppress invasion and metastasis.

Indexed as

Genes, rasMutationPromoter Regions, GeneticCell Line, TumorEnzyme ActivationGene Knockdown TechniquesHumansNeoplasm InvasivenessNeoplasm MetastasisPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktWiskott-Aldrich Syndrome Protein FamilyPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktWASF3 protein, humanWiskott-Aldrich Syndrome Protein Family

Identifiers

PMID28233357
PMCPMC5609680
OpenAlexW2590929048

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.